Mgr. Karla Plevová, Ph.D.
Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Office: bldg. E35/258
Kamenice 753/5
625 00 Brno
Phone: | +420 532 23 4396 |
---|---|
E‑mail: | |
Web: | https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us |
social and academic networks: |
---|
Total number of publications: 354
2013
-
Distinct frequency and profiles of TP53 gene mutations in CLL subgroups with distinct antigen receptors: Evidence for antigen-driven selection of genomci aberrations.
Year: 2013, type: Conference abstract
-
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.
Leukemia, year: 2013, volume: 27, edition: 11, DOI
-
Dráha Wnt/PCP ovlivňuje kromě patogeneze chronické lymfocytární leukemie i vývoj B-lymfocytů
Year: 2013, type: Conference abstract
-
Klonální evoluce a selekce mutací TP53 v relapsu chronické lymfocytární leukémie
Year: 2013, type:
-
Metodou RT-qPCR k predikci vývoje chronické lymfocytární leukémie (CLL)
Year: 2013, type: Conference abstract
-
Molekulární biologie CLL - význam molekulárních prognostických faktorů
Year: 2013, type:
-
Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life
Year: 2013, type: Conference abstract
-
Role of Wnt-5A and non-canonical Wnt signaling in chronic lymphocytic leukemia
Year: 2013, type: Conference abstract
-
SF3B1 mutations frequently occur with both ATM mutations and TP53 mutations in CLL patients
Year: 2013, type: Conference abstract
-
Stanovení prognózy pacientů s chronickou lymfocytární leukémií (CLL)
Year: 2013, type: Conference abstract